What is the share price of Chandra Bhagat Pharma Ltd (CBPL) today?
The share price of CBPL as on 5th November 2026 is ₹58. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Chandra Bhagat Pharma Ltd (CBPL) share?
The past returns of Chandra Bhagat Pharma Ltd (CBPL) share are- Past 1 week: 11.77%
- Past 1 month: 17.41%
- Past 3 months: 47.36%
- Past 6 months: 83.54%
- Past 1 year: 44.96%
- Past 3 years: -42.72%
- Past 5 years: -21.09%
What are the peers or stocks similar to Chandra Bhagat Pharma Ltd (CBPL)?
The peers or stocks similar to Chandra Bhagat Pharma Ltd (CBPL) include:What is the market cap of Chandra Bhagat Pharma Ltd (CBPL) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Chandra Bhagat Pharma Ltd (CBPL) is ₹43.20 Cr as of 5th November 2026.What is the 52 week high and low of Chandra Bhagat Pharma Ltd (CBPL) share?
The 52-week high of Chandra Bhagat Pharma Ltd (CBPL) is ₹60.06 and the 52-week low is ₹29.70.What is the PE and PB ratio of Chandra Bhagat Pharma Ltd (CBPL) stock?
The P/E (price-to-earnings) ratio of Chandra Bhagat Pharma Ltd (CBPL) is 14.16. The P/B (price-to-book) ratio is 1.30.Which sector does Chandra Bhagat Pharma Ltd (CBPL) belong to?
Chandra Bhagat Pharma Ltd (CBPL) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Chandra Bhagat Pharma Ltd (CBPL) shares?
You can directly buy Chandra Bhagat Pharma Ltd (CBPL) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Chandra Bhagat Pharma Ltd
CBPL Share Price
BSE₹58.001.31% (+0.75)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP
CBPL Stock Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
AvgFinancials growth has been moderate for a few years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
CBPL Performance & Key Metrics
CBPL Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.30 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 43.84 | 5.87 | 0.49% |
CBPL Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
CBPL Company Profile
Chandra Bhagat Pharma Ltd markets pharmaceutical critical care products, focusing on formulations for hospitals and healthcare centers, including injections and active pharmaceutical ingredients.
PE Ratio
34.10
34.10
1Y Return
8.90%
8.90%
Buy Reco %
93.55
93.55
TORNTPHARM
PE Ratio
81.89
81.89
1Y Return
32.27%
32.27%
Buy Reco %
85.19
85.19
LAURUSLABS
PE Ratio
141.27
141.27
1Y Return
138.67%
138.67%
Buy Reco %
61.54
61.54
ZYDUSLIFE
PE Ratio
21.59
21.59
1Y Return
28.15%
28.15%
Buy Reco %
57.69
57.69
PE Ratio
27.28
27.28
1Y Return
13.31%
13.31%
Buy Reco %
67.74
67.74
CBPL Forecast
CBPL Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
CBPL
CBPL
Income
Balance Sheet
Cash Flow
Quarterly Normal View
CBPL Income Statement
CBPL Income Statement
Quarterly Normal View
Hmm, looks like data is unavailable here. Please come back after some timeCBPL Company Updates
CBPL Stock Peers
CBPL Past Performance & Peer Comparison
CBPL Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Chandra Bhagat Pharma Ltd | 14.16 | 1.30 | — |
| Sun Pharmaceutical Industries Limited | 34.10 | 5.07 | 0.90% |
| Torrent Pharmaceuticals Ltd | 81.89 | 10.25 | 0.71% |
| Laurus Labs Ltd | 141.27 | 23.12 | 0.09% |
Compare valuation on ScreenerCBPL Stock Price Comparison
Compare CBPL with any stock or ETFCompare CBPL with any stock or ETF
CBPL
CBPL Holdings
CBPL Shareholdings
CBPL Promoter Holdings Trend
CBPL Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
CBPL Institutional Holdings Trend
CBPL Institutional Holdings Trend
No institutional holdings trend are available
CBPL Shareholding Pattern
CBPL Shareholding Pattern
CBPL Shareholding History
CBPL Shareholding History
Foreign Institutions
smallcases containing CBPL stock
smallcases containing CBPL stock
Looks like this stock is not in any smallcase yet.
CBPL Events
CBPL Events
CBPL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CBPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
CBPL Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
CBPL has not given any dividends in last 5 years
CBPL Dividends
CBPL Dividends
Hmm, looks like data is unavailable here. Please come back after some timeCBPL Stock News & Opinions
CBPL Stock News & Opinions
Articles & Videos
Corporate
Corporate
Chandra Bhagat Pharma halts securities trading for insiders pending financial resultsChandra Bhagat Pharma Limited informed the BSE Limited that it has closed the trading window for dealing in the company's securities for all directors, officers, and key managerial personnel, effective immediately, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015. The trading window will reopen 48 hours after the announcement of the financial results for the half year ended September 30, 2026.
1 month agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma Limited announces Rajani Dawani's resignation as Company SecretaryChandra Bhagat Pharma Limited informed the BSE Limited that Rajani Dawani resigned from the post of Company Secretary (CS) of the company, effective September 30, 2026, due to preoccupation in other assignments.
1 month agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma to consider fund raising and shareholder meeting on August 5Chandra Bhagat Pharma Limited will hold a board meeting on Wednesday, August 5, 2026, to consider a proposal for fund raising by way of issuing equity shares or convertible warrants and to fix the date, time, and place for an Extraordinary General Meeting to obtain shareholder approval for the preferential issue, among other agenda items; the trading window for dealing in the company's securities will be closed for connected persons from July 30, 2026, until 48 hours after the board meeting's conclusion.
3 months agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma to conduct board meetingChandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 25 May 2026.
5 months agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma to discuss resultsChandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma AGM scheduledChandra Bhagat Pharma announced that the Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma to conduct board meetingChandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma schedules board meetingChandra Bhagat Pharma will hold a meeting of the Board of Directors of the Company on 13 November 2024Powered by Capital Market - Live
1 year agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma to conduct AGMChandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
2 years agoCapital Market - Live
Corporate
Corporate
Chandra Bhagat Pharma schedules AGMChandra Bhagat Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live
2 years agoCapital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 10.94%, vs industry avg of 10.72%
Over the last 5 years, market share stayed at 0.02%
Over the last 5 years, net income has grown at a yearly rate of 72.33%, vs industry avg of 10.43%